Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Assenat

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Long-term outcomes of liver transplantation: diabetes mellitusGeorges-Philippe Pageaux, Stéphanie Faure, Hassan Bouyabrine, et al.
Clinical & Experimental Metastasis|November 10, 2014
Bone metastases in gastrointestinal cancerFabienne Portales, Simon Thézenas, Emmanuelle Samalin, et al.
BMC Cancer|December 22, 2022
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, et al.
World Journal of Gastroenterology|August 3, 2010
Is chronic hepatitis C virus infection a risk factor for breast cancer?Dominique Larrey, Marie-Cécile Bozonnat, Ihab Kain, et al.
BMJ Open|August 17, 2025
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancerFabienne Portales, Sophie Gourgou, Catherine Fiess, et al.
Molecular Cancer|February 9, 2021
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clonesLaure Cayrefourcq, Frédéric Thomas, Thibault Mazard, et al.
Clinical Chemistry|December 24, 2016
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA RepairCatherine Alix-Panabières, Laure Cayrefourcq, Thibault Mazard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2006
Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?Eric Assenat, Sabine Gerbal-chaloin, Patrick Maurel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2021
Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositisCyrille Coustal, Aurélie Du Thanh, François Roubille, et al.
Cancer Treatment Reviews|May 6, 2008
Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit?Pierre Senesse, Eric Assenat, Stéphane Schneider, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Long-term outcomes of liver transplantation: diabetes mellitusGeorges-Philippe Pageaux, Stéphanie Faure, Hassan Bouyabrine, et al.
Clinical & Experimental Metastasis|November 10, 2014
Bone metastases in gastrointestinal cancerFabienne Portales, Simon Thézenas, Emmanuelle Samalin, et al.
BMC Cancer|December 22, 2022
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, et al.
World Journal of Gastroenterology|August 3, 2010
Is chronic hepatitis C virus infection a risk factor for breast cancer?Dominique Larrey, Marie-Cécile Bozonnat, Ihab Kain, et al.
BMJ Open|August 17, 2025
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancerFabienne Portales, Sophie Gourgou, Catherine Fiess, et al.
Molecular Cancer|February 9, 2021
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clonesLaure Cayrefourcq, Frédéric Thomas, Thibault Mazard, et al.
Clinical Chemistry|December 24, 2016
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA RepairCatherine Alix-Panabières, Laure Cayrefourcq, Thibault Mazard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2006
Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?Eric Assenat, Sabine Gerbal-chaloin, Patrick Maurel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2021
Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositisCyrille Coustal, Aurélie Du Thanh, François Roubille, et al.
Cancer Treatment Reviews|May 6, 2008
Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit?Pierre Senesse, Eric Assenat, Stéphane Schneider, et al.
Pageof 16